biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
23:41 Melanoma cell therapy controlled by an approved drug enrolls new groups✦23:41 ADHD drugs may ease perimenopause brain fog, early review suggests✦23:36 $1.55 billion pill for rare muscle disease failed big trial, maker says✦17:44 Lab study points to a protein that may help drive aging in testicles✦17:43 Trial will test whether stool-transplant capsules slow aging in 68 adults✦17:39 Novartis pill cut MS relapses more than an older drug in two big trials✦11:36 Women on menopause hormones lost a bit more weight on Ozempic-style drugs✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦23:41 Melanoma cell therapy controlled by an approved drug enrolls new groups✦23:41 ADHD drugs may ease perimenopause brain fog, early review suggests✦23:36 $1.55 billion pill for rare muscle disease failed big trial, maker says✦17:44 Lab study points to a protein that may help drive aging in testicles✦17:43 Trial will test whether stool-transplant capsules slow aging in 68 adults✦17:39 Novartis pill cut MS relapses more than an older drug in two big trials✦11:36 Women on menopause hormones lost a bit more weight on Ozempic-style drugs✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study
← All story threadsSTORY THREAD

Switchable immune cell therapy for melanoma.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 3, 2026
    TRIAL RECRUITING NEW GROUPS OF MELANOMA PATIENTSEarly company-reported data

    Melanoma cell therapy controlled by an approved drug enrolls new groups

    An experimental treatment uses immune cells taken from a patient's own tumor, then switched on with an approved drug. Its trial is now recruiting new groups of melanoma patients.